Modeling Ribavirin‐Induced Anemia in Patients with Chronic Hepatitis C Virus

Ribavirin remains an important component of hepatitis C treatment in certain clinical scenarios, but it causes hemolytic anemia. A quantitative understanding of the ribavirin exposure‐anemia relationship is important in dose individualization/optimization. We developed a model relating ribavirin tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, LS, Jimmerson, LC, MacBrayne, CE, Kiser, JJ, D'Argenio, DZ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761234/
https://www.ncbi.nlm.nih.gov/pubmed/26933517
http://dx.doi.org/10.1002/psp4.12058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761234/
https://www.ncbi.nlm.nih.gov/pubmed/26933517
http://dx.doi.org/10.1002/psp4.12058

Ejemplares similares